Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT02997332 · TERMINATED
Trial details
- NCT number
- NCT02997332
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-30
- Primary completion
- 2020-03-17
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.